THE LOWEST EFFECTIVE DOSE OF PROSTAGLANDIN-E1 AS TREATMENT FOR ERECTILE DYSFUNCTION

被引:13
作者
CHEN, JZ
GODSCHALK, M
KATZ, PG
MULLIGAN, T
机构
[1] HUNTER HOLMES MCGUIRE VET AFFAIRS MED CTR,DIV GERIATR MED,RICHMOND,VA
[2] VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,RICHMOND,VA
关键词
PENILE ERECTION; PENIS; IMPOTENCE; DRUG THERAPY; PROSTAGLANDINS E;
D O I
10.1097/00005392-199501000-00028
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The recommended dose of prostaglandin E1 as treatment for erectile dysfunction has been reported to be 10 to 40 mu g. However, adverse effects probably increase with increasing doses. We conducted a prospective, single-blind, dose-escalating study of prostaglandin E1 on 20 men with erectile dysfunction of various etiologies. The response to prostaglandin E1 was assessed by penile palpation and RigiScan* rigidity monitoring. A total of 17 patients completed the study: 1 achieved rigidity with 1 mu g., 2 with 2 mu g. and 4 with 3 mu g. prostaglandin E1, while more than 70% achieved rigidity with 5 mu g. or less and more than 80% had a full erection with 20 mu g. Of 138 injections there were 2 episodes of pain after injection. We conclude that the often recommended starting dose of 20 mu g. is too high. A more appropriate starting dose is 2.5 mu g. with increments of 2.5 mu g. until the lowest effective dose is achieved. This approach may lessen the major impediments to prostaglandin E1 use, that is burning and pain.
引用
收藏
页码:80 / 81
页数:2
相关论文
共 15 条
[2]   PHARMACOLOGICAL ERECTION PROGRAM USING PROSTAGLANDIN-E1 [J].
GERBER, GS ;
LEVINE, LA .
JOURNAL OF UROLOGY, 1991, 146 (03) :786-789
[3]   TREATMENT OF ERECTILE FAILURE WITH PROSTAGLANDIN-E1 - A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY [J].
GODSCHALK, MF ;
CHEN, JZ ;
KATZ, PG ;
MULLIGAN, T .
JOURNAL OF UROLOGY, 1994, 151 (06) :1530-1532
[4]   IMPOTENCE EVALUATED BY THE USE OF PROSTAGLANDIN-E1 [J].
HWANG, TIS ;
YANG, CR ;
WANG, SJ ;
CHANG, CL ;
TZAI, TS ;
CHANG, CH ;
WU, HC .
JOURNAL OF UROLOGY, 1989, 141 (06) :1357-1359
[5]   INTRACAVERNOUS INJECTION OF PROSTAGLANDIN-E1 FOR THE TREATMENT OF ERECTILE IMPOTENCE [J].
ISHII, N ;
WATANABE, H ;
IRISAWA, C ;
KIKUCHI, Y ;
KUBOTA, Y ;
KAWAMURA, S ;
SUZUKI, K ;
CHIBA, R ;
TOKIWA, M ;
SHIRAI, M .
JOURNAL OF UROLOGY, 1989, 141 (02) :323-325
[6]   PHYSIOLOGY OF ERECTION AND PHARMACOLOGICAL MANAGEMENT OF IMPOTENCE [J].
LUE, TF ;
TANAGHO, EA .
JOURNAL OF UROLOGY, 1987, 137 (05) :829-836
[7]   DOSE-DEPENDENT EFFECT AND SIDE-EFFECT OF PROSTAGLANDIN-E1 IN ERECTILE DYSFUNCTION [J].
SCHRAMEK, P ;
WALDHAUSER, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (05) :567-571
[8]   PROSTAGLANDIN-E1 IN ERECTILE DYSFUNCTION - EFFICIENCY AND INCIDENCE OF PRIAPISM [J].
SCHRAMEK, P ;
DORNINGER, R ;
WALDHAUSER, M ;
KONECNY, P ;
PORPACZY, P .
BRITISH JOURNAL OF UROLOGY, 1990, 65 (01) :68-71
[9]   INTRACAVERNOUS INJECTION OF PROSTAGLANDIN-E1 IN IMPOTENT MEN [J].
STACKL, W ;
HASUN, R ;
MARBERGER, M .
JOURNAL OF UROLOGY, 1988, 140 (01) :66-68
[10]   EFFECTS OF PROSTAGLANDIN-E1 ON PENILE ERECTION AND ERECTILE FAILURE [J].
VIRAG, R ;
ADAIKAN, PG .
JOURNAL OF UROLOGY, 1987, 137 (05) :1010-1010